Molecular Imaging: Page 2

PET scans can reduce unnecessary lymph node procedures

By Will Morton

Negative prostate-specific antigen PET scans can be used to avoid unnecessary pelvic lymph node dissection in certain prostate cancer patients undergoing radical prostatectomies.

January 10, 2025

Spanish team unveils SPECT-based coronary risk score for women

By Will Morton

A new risk score based on SPECT imaging and other variables can accurately predict risks for women of major adverse cardiovascular events.

December 10, 2024

PET/CT proves value in patients with hyperparathyroidism

By Will Morton

A French group has reported that F-18 fluorocholine PET/CT appears to be an effective first-line imaging method in patients with primary hyperparathyroidism.

November 4, 2024

New study highlights long-term benefits of PSMA-PET

By Will Morton

Prostate-specific membrane antigen (PSMA) PET imaging can improve the length and quality of life for patients with recurrent prostate cancer, researchers have reported.

October 28, 2024

ESMIT highlights standout sessions for EANM 2024

By AuntMinnieEurope.com staff writers

The European School of Multimodality Imaging and Therapy (ESMIT) has given advice to attendees ahead of the annual congress of the European Association of Nuclear Medicine (EANM) in Hamburg, Germany.

October 18, 2024

GEHC announces new theranostics center in Germany

By AuntMinnieEurope.com staff writers

GE HealthCare (GEHC) is collaborating with University Medicine Essen in Germany to establish a new Theranostics Center of Excellence.

October 16, 2024

New guidelines cover theranostics for brain tumors

By Will Morton

The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new recommendations can help pave the way to improved outcomes for patients.

October 16, 2024

Swiss overcome logistical issues in clinical audits

By Edna Astbury-Ward, PhD

Clinical audits in radiation protection are proving valuable in Switzerland, but serious challenges have arisen due to the country's four official languages and diverse regional cultures.

September 26, 2024

Targeted prostate therapy displays clinical promise

By Will Morton

An emerging radiopharmaceutical treatment seems to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval.

September 25, 2024

Microplastics reach the olfactory bulb in the human brain

By Will Morton

Researchers have detected microplastics in olfactory bulb brain tissues of eight deceased individuals, and they suggest MRI could be the next step for studying the effects of the pollutants on human health.

September 23, 2024

Radiotracer for kidney cancer performs well in phase III trial

By Will Morton

A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and highly effective in a clinical trial conducted at 36 research hospitals across nine countries.

September 13, 2024

Mevion, Nelco to partner on proton therapy

By AuntMinnieEurope.com staff writers

Mevion Medical Systems and Nelco Worldwide are collaborating on the faster adoption of proton therapy.

September 13, 2024

Previous Page

Page 2 of 118

Next Page